The medication has been linked to a lower overall incidence of chronic disease, with one Swiss study projecting a 6.4% reduction in the annual death rate by 2045
In fact, this effect isnt unique to GLP-1 RAs
Patients who used Zepbound for 36 weeks lost an average of 21%, but then, when switched to a placebo, after 1 year, they had regained 14% of their weight back
Food allergen-directed immunotherapies function by inducing food desensitization, such as Palforzia for peanut allergy, with disadvantages including adverse reactions, ineffectiveness in adults and for severe cases, and relapses upon cessation of therapy
In clinical trials, Tirzepatide showed slightly greater weight loss on average, but the best choice depends on your individual health profile, insurance coverage, and how your body responds
Combination therapy showed additive effects on suppressing non-fasting blood glucose levels, plasma insulin levels, A 1C levels and lipid parameters